EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Arachidonic acid metabolism in health and disease

Yiran Zhang, Yingxiang Liu, Jin Sun, Wei Zhang, Zheng Guo, Qiong Ma

MedComm · 2023-10 · 4 (5)

DOI: 10.1002/mco2.363 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 20.09.2023. Verfasst von Yiran Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery Orthopedic Oncology Institute The Second Affiliated Hospital of Air Force Medical University Xi'an China. Die Arbeit wurde bisher 298-mal zitiert (Crossref) und nennt 321 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arachidonic acid (AA), an n‐6 essential fatty acid, is a major component of mammalian cells and can be released by phospholipase A2. Accumulating evidence indicates that AA plays essential biochemical roles, as it is the direct precursor of bioactive lipid metabolites of eicosanoids such as prostaglandins, leukotrienes, and epoxyeicosatrienoic acid obtained from three distinct enzymatic metabolic pathways: the cyclooxygenase pathway, lipoxygenase pathway, and cytochrome P450 pathway. AA metabolism is involved not only in cell differentiation, tissue development, and organ function but also in the progression of diseases, such as hepatic fibrosis, neurodegeneration, obesity, diabetes, and cancers. These eicosanoids are generally considered proinflammatory molecules, as they can trigger oxidative stress and stimulate the immune response. Therefore, interventions in AA metabolic pathways are effective ways to manage inflammatory‐related diseases in the clinic. Currently, inhibitors targeting enzymes related to AA metabolic pathways are an important area of drug discovery. Moreover, many advances have also been made in clinical studies of AA metabolic inhibitors in combination with chemotherapy and immunotherapy. Herein, we review the discovery of AA and focus on AA metabolism in relation to health and diseases. Furthermore, inhibitors targeting AA metabolism are summarized, and potential clinical applications are discussed.

Schlagwörter

Stichwörter der Autor:innen

arachidonic acidbioactive lipid metabolitesorgan homeostasistargeted therapy

Autor:innen und Institutionen

  • Department of Orthopedic Surgery Orthopedic Oncology Institute The Second Affiliated Hospital of Air Force Medical University Xi'an China.
  • Department of Pathology The Second Affiliated Hospital of Air Force Medical University Xi'an China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Y., Liu, Y., Sun, J., Zhang, W., Guo, Z., & Ma, Q. (2023). Arachidonic acid metabolism in health and disease. MedComm, 4(5). https://doi.org/10.1002/mco2.363

Vancouver

Zhang Y, Liu Y, Sun J, Zhang W, Guo Z, Ma Q. Arachidonic acid metabolism in health and disease. MedComm. 2023;4(5). doi:10.1002/mco2.363

BibTeX
@article{Zhang2023,
  author = {Zhang, Yiran and Liu, Yingxiang and Sun, Jin and Zhang, Wei and Guo, Zheng and Ma, Qiong},
  title = {Arachidonic acid metabolism in health and disease},
  journal = {MedComm},
  year = {2023},
  volume = {4},
  number = {5},
  doi = {10.1002/mco2.363}
}
Kostenlos starten →